Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

515 ARTÍCULOS , VIENDO DEL 211 AL 225

Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS

Bonini NM, Gitler AD.

J Mol Neurosci. 2011 Nov;45(3):676-83. doi: 10.1007/s12031-011-9548-9. Epub 2011 Jun 10.

Severe back pain following epidural analgesia in patients with spinocerebellar ataxia: a report of two cases

Iida R, Kato J, Ogawa S.

J Clin Anesth. 2011 Jun;23(4):314-7. doi: 10.1016/j.jclinane.2010.07.003.

Ataxia is still an important clinical finding in severe high altitude illness

Grissom CK.

Wilderness Environ Med. 2011 Jun;22(2):105-6. doi: 10.1016/j.wem.2011.03.006.

High altitude ataxia--its assessment and relevance

Bird BA, Wright AD, Wilson MH, Johnson BG, Imray CH; Birmingham Medical Research Expeditionary Society.

Wilderness Environ Med. 2011 Jun;22(2):172-6. doi: 10.1016/j.wem.2011.02.001.

Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis

Seif AE.

Cancer Genet. 2011 May;204(5):227-44. doi: 10.1016/j.cancergen.2011.04.005.

Elucidation of the molecular mechanism and exploration of novel therapeutics for spinocerebellar ataxia caused by mutant protein kinase Cγ

Seki T, Adachi N, Abe-Seki N, Shimahara T, Takahashi H, Yamamoto K, Saito N, Sakai N.

J Pharmacol Sci. 2011;116(3):239-47. doi: 10.1254/jphs.11r04cp. Epub 2011 Jun 10.

Acute cerebellar ataxia in lupus

Chattopadhyay P, Dhua D, Philips CA, Saha S.

Lupus. 2011 Oct;20(12):1312-5. doi: 10.1177/0961203311403346. Epub 2011 Jun 13.

Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond

McKeon A, Tracy JA, Pittock SJ, Parisi JE, Klein CJ, Lennon VA.

Arch Neurol. 2011 Oct;68(10):1282-9. doi: 10.1001/archneurol.2011.128. Epub 2011 Jun 13.

Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis

Daoud H, Belzil V, Martins S, Sabbagh M, Provencher P, Lacomblez L, Meininger V, Camu W, Dupré N, Dion PA, Rouleau GA.

Arch Neurol. 2011 Jun;68(6):739-42. doi: 10.1001/archneurol.2011.111.

Unique and redundant functions of ATM and DNA-PKcs during V(D)J recombination

Gapud EJ, Sleckman BP.

Cell Cycle. 2011 Jun 15;10(12):1928-35. doi: 10.4161/cc.10.12.16011. Epub 2011 Jun 15.

Progressive dementia associated with ataxia or obesity in patients with Tropheryma whipplei encephalitis

Fenollar F, Nicoli F, Paquet C, Lepidi H, Cozzone P, Antoine JC, Pouget J, Raoult D.

BMC Infect Dis. 2011 Jun 15;11:171. doi: 10.1186/1471-2334-11-171.

[Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases]

Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Sedel F, Guennoc AM, Sartori E, Laplaud D, Antoine JC, Fogli A, Boespflug-Tanguy O, Labauge P.

Rev Neurol (Paris). 2011 Nov;167(11):802-11. doi: 10.1016/j.neurol.2011.03.008. Epub 2011 Jun 14.

The ciliopathies in neuronal development: a clinical approach to investigation of Joubert syndrome and Joubert syndrome-related disorders

Sattar S, Gleeson JG.

Dev Med Child Neurol. 2011 Sep;53(9):793-798. doi: 10.1111/j.1469-8749.2011.04021.x. Epub 2011 Jun 17.

Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies

Ali F, Rowley M, Jayakrishnan B, Teuber S, Gershwin ME, Mackay IR.

J Autoimmun. 2011 Sep;37(2):79-87. doi: 10.1016/j.jaut.2011.05.005. Epub 2011 Jun 16.

The importance of methylmalonic acid dosage on the assessment of patients with neurological manifestations following bariatric surgery

Vieira C, Cosmo C, Lucena R.

Obes Surg. 2011 Dec;21(12):1971-4. doi: 10.1007/s11695-011-0449-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias